Park Paul H, Davey Sonya, Fehr Alexandra E, Butonzi John, Shyirambere Cyprien, Hategekimana Vedaste, Bigirimana Jean Bosco, Borg Ryan, Uwizeye Regis, Tapela Neo, Shulman Lawrence N, Randall Thomas, Mpanumusingo Egide, Mpunga Tharcisse
Paul H. Park, Alexandra E. Fehr, Cyprien Shyirambere, Jean Bosco Bigirimana, Ryan Borg, Regis Uwizeye, and Egide Mpanumusingo, Partners In Health/Inshuti Mu Buzima, Rwinkwavu; John Butonzi, Vedaste Hategekimana, and Tharcisse Mpunga, Butaro District Hospital, Rwanda Ministry of Health, Butaro, Rwanda; Sonya Davey and Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Paul H. Park and Neo Tapela, Brigham and Women's Hospital; Paul H. Park, Harvard Medical School; Thomas Randall, Harvard Medical School, and Massachusetts General Hospital, Boston, MA; and Neo Tapela, Oxford University, Oxford, United Kingdom.
J Glob Oncol. 2018 Dec;4:1-11. doi: 10.1200/JGO.18.00120.
Low- and middle-income countries account for 86% of all cervical cancer cases and 88% of cervical cancer mortality globally. Successful management of cervical cancer requires resources that are scarce in sub-Saharan Africa, especially in rural settings. Here, we describe the early clinical outcomes and implementation lessons learned from the Rwanda Ministry of Health's first national cancer referral center, the Butaro Cancer Center of Excellence (BCCOE). We hypothesize that those patients presenting at earlier stage and receiving treatment will have higher rates of being alive.
The implementation of cervical cancer services included developing partnerships, clinical protocols, pathology services, and tools for monitoring and evaluation. We conducted a retrospective study of patients with cervical cancer who presented at BCCOE between July 1, 2012, and June 30, 2015. Data were collected from the electronic medical record system and by manually reviewing medical records. Descriptive, bivariable and multivariable statistical analyses were conducted to describe patient demographics, disease profiles, treatment, and clinical outcomes.
In all, 373 patients met the study inclusion criteria. The median age was 53 years (interquartile rage, 45 to 60 years), and 98% were residents of Rwanda. Eighty-nine percent of patients had a documented disease stage: 3% were stage I, 48% were stage II, 29% were stage III, and 8% were stage IV at presentation. Fifty percent of patients were planned to be treated with a curative intent, and 54% were referred to chemoradiotherapy in Uganda. Forty percent of patients who received chemoradiotherapy were in remission. Overall, 25% were lost to follow-up.
BCCOE illustrates the feasibility and challenges of implementing effective cervical cancer treatment services in a rural setting in a low-income country.
低收入和中等收入国家的宫颈癌病例占全球所有宫颈癌病例的86%,宫颈癌死亡病例占全球的88%。成功管理宫颈癌需要资源,而撒哈拉以南非洲地区,尤其是农村地区,资源稀缺。在此,我们描述了卢旺达卫生部首个国家癌症转诊中心——布塔罗卓越癌症中心(BCCOE)的早期临床结果以及实施经验教训。我们假设那些处于较早期阶段并接受治疗的患者存活几率更高。
宫颈癌服务的实施包括建立合作伙伴关系、制定临床方案、病理服务以及监测和评估工具。我们对2012年7月1日至2015年6月30日期间在BCCOE就诊的宫颈癌患者进行了回顾性研究。数据从电子病历系统收集,并通过人工查阅病历获取。进行了描述性、双变量和多变量统计分析,以描述患者人口统计学特征、疾病概况、治疗情况和临床结果。
共有373名患者符合研究纳入标准。中位年龄为53岁(四分位间距为45至60岁),98%为卢旺达居民。89%的患者有记录在案的疾病分期:就诊时3%为I期,48%为II期,29%为III期,8%为IV期。50%的患者计划接受根治性治疗,54%被转诊至乌干达接受放化疗。接受放化疗的患者中有40%病情缓解。总体而言,25%的患者失访。
BCCOE说明了在低收入国家农村地区实施有效的宫颈癌治疗服务的可行性和挑战。